Differential Requirements of MHC and of DCs for Endogenous Proliferation of Different T-cell Subsets in Vivo
Overview
Authors
Affiliations
T cells transferred into severe lymphopenic hosts undergo rapid proliferation known as "endogenous proliferation" that are distinct from conventional homeostatic proliferation. Unlike homeostatic proliferation, cytokines, such as IL-7 are dispensable, yet TCR:MHC interaction is essential for this process to occur. However, cell types inducing the proliferation have not formally been addressed. In this study, we report that CD11c+ conventional DCs play irreplaceable roles in inducing endogenous proliferation of both naive and memory phenotype CD4 T cells via TCR-MHC II interaction. By contrast, CD8 T-cell endogenous proliferation was independent of MHC I or CD11c+ DCs. Interestingly, MHC II was necessary to support naive CD8 T-cell proliferation within MHC I-deficient hosts. Depletion of both B cells and DCs was sufficient to abrogate the proliferation of naive but not of memory CD8 T cells. These results suggest that depending on the T-cell lineages, as well as the differentiation status, different mechanisms control endogenous proliferation, revealing in vivo complexity of T-cell proliferation under lymphopenic conditions.
Li J, Yang Z, Kawajiri A, Sato K, Tayama S, Ishii N Front Immunol. 2024; 15:1429954.
PMID: 39221254 PMC: 11361994. DOI: 10.3389/fimmu.2024.1429954.
Bharadwaj N, Zumwalde N, Kapur A, Patankar M, Gumperz J iScience. 2024; 27(5):109775.
PMID: 38726371 PMC: 11079467. DOI: 10.1016/j.isci.2024.109775.
Emerging strategies for treating autoimmune disease with genetically modified dendritic cells.
Ma Y, Shi R, Li F, Chang H Cell Commun Signal. 2024; 22(1):262.
PMID: 38715122 PMC: 11075321. DOI: 10.1186/s12964-024-01641-7.
TSLP/dendritic cell axis promotes CD4+ T cell tolerance to the gut microbiome.
Messerschmidt J, Azin M, Dempsey K, Demehri S JCI Insight. 2023; 8(13).
PMID: 37427591 PMC: 10371333. DOI: 10.1172/jci.insight.160690.
Downregulation of MALAT1 is a hallmark of tissue and peripheral proliferative T cells in COVID-19.
Dey S, Ashwin H, Milross L, Hunter B, Majo J, Filby A Clin Exp Immunol. 2023; 212(3):262-275.
PMID: 36869729 PMC: 10243916. DOI: 10.1093/cei/uxad034.